We agree with Natalie (one of our external experts) about the requirements for a good model. We did a cool video to explain it: 📽️youtube.com/watch?v=uWuNfh…

The first 4 of 6 criteria relate to the #molecularcharacterization of the #geneticmodification introduced in the recipient plant, criterion 5 looks at history of use, then 6 requires assessing structure & function of the modified allele versions of the #DNA sequence

✍️#SaveTheDate | 📅15 to 16 Feb 2023 We're holding a workshop to disseminate the revised methodology for #BenchmarkDose (BMD) analysis in EFSA updated Guidance document & to support its implementation in the BMD platform Registration available soon 👉europa.eu/!CmKqKh

Day 2 of the 28th #Emergingrisks exchange network EFSA Member states present and discuss signals.

Registrations are open! Funding opportunities in the EFSA 2023 Workplan | EFSA europa.eu/!mFyqkd via EFSA

From identifying data for #RiskAssessment to supporting a transition to lower #environmental impacts, #ArtificialIntelligence is🗝️to fostering a #OneHealth approach. Interested to know more?🤩 Register for our Live EU AI Talk! 📅30/11/22 ⏰23/11/22 👉europa.eu/!P9dfxx

Tomorrow is the day! We will explore how #ArtificialIntelligence in the public sector 🏛️ can grow from a grassroots movement to a driver of change. 🌐🚀🤖 Check out the trailer before the event starts and leave us a like.👇

ICYMI our new report with EU Medicines Agency compares how we estimate acute and chronic #dietaryexposure from different models & proposes harmonised approaches for doing exposure estimates, which models to use, consumption data, residue input assumptions, & use in #RiskAssessment

🔴 Live now | Workshop on EFSA updated Guidance on the use of the #BenchmarkDose approach in #RiskAssessment 💻Watch the live streaming 👇 europa.eu/!P7YPBT

⁦EFSA⁩ ⁦Methods EFSA⁩ ⁦Didier Verloo⁩ great talk at ⁦Society of Toxicology⁩ on building pullulation variability into PBK models and ADME